Percutaneous Endoscopic Gastrostomy Kit Market

The global Percutaneous Endoscopic Gastrostomy Kit Market size was USD 728.4 million in 2024 and the market is projected to touch USD 1289.5 million by 2031, exhibiting a CAGR of 8.5% during the forecast period.

The percutaneous endoscopic gastrostomy (PEG) kit market has witnessed substantial growth in recent years, driven by the rising prevalence of dysphagia, neurological disorders, and gastrointestinal diseases requiring long-term enteral feeding. Percutaneous endoscopic gastrostomy is a minimally invasive procedure used to provide nutrition to patients who cannot swallow adequately. The PEG kit comprises essential components such as gastrostomy tubes, endoscopes, guidewires, and fixation devices. As the demand for enteral feeding solutions continues to rise globally, fuelled by an aging population and increasing incidence of chronic illnesses, the PEG kit market is poised for further expansion. This introduction sets the stage for exploring the dynamics, trends, and factors influencing the growth of the percutaneous endoscopic gastrostomy kit market.

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic has exerted significant disruptions on the percutaneous endoscopic gastrostomy (PEG) kit market, primarily through supply chain interruptions. Lockdown measures and restrictions on movement implemented to curb the spread of the virus have severely impacted the production and transportation of PEG kits. Manufacturers faced challenges in sourcing raw materials, assembling components, and distributing finished products due to factory closures, labor shortages, and logistical constraints. These disruptions resulted in shortages of PEG kits in certain regions, exacerbating the strain on healthcare facilities already grappling with increased patient volumes. Moreover, the erratic supply chain dynamics led to price fluctuations, further complicating procurement efforts for healthcare providers and institutions. As the pandemic unfolded, the PEG kit market confronted unprecedented challenges in maintaining consistent supply levels, underscoring the vulnerability of the healthcare supply chain to global crises.

"Minimally invasive procedures to propel market growth"

Recent advancements in medical technology have facilitated the development of smaller, more flexible scopes and refined techniques for PEG placements. These innovations allow healthcare providers to perform PEG procedures with greater precision and ease, minimizing trauma to surrounding tissues and reducing the risk of complications. Patients undergoing minimally invasive PEG placements experience faster recovery times and diminished post-operative discomfort compared to traditional surgical methods. Additionally, the less invasive nature of these procedures makes them suitable for a wider range of patients, including those with compromised health conditions. As healthcare professionals prioritize patient comfort and safety, the demand for minimally invasive PEG kits is expected to continue growing, driving further innovation and refinement in this segment of the market.

By Type

Based on type the market can be categorized into Polyurethane and Polyvinyl Chloride.

• Polyurethane: Polyurethane gastrostomy kits are known for their flexibility and durability, making them suitable for long-term use. They offer a softer, more comfortable feel for patients during insertion and while in place. Additionally, polyurethane is less likely to cause skin irritation or allergic reactions compared to other materials.

• Polyvinyl Chloride (PVC): PVC gastrostomy kits are cost-effective and widely used due to their affordability and availability. While not as flexible as polyurethane, PVC tubes still provide adequate functionality for patients requiring short-term or temporary feeding access. However, they may be associated with a higher risk of skin irritation or sensitivity.

By Application

Based on application the market can be categorized into Children and Adults.

• Children: These kits often feature smaller tube sizes, softer materials, and specialized accessories suitable for the delicate anatomy and nutritional requirements of children. They are crucial in providing essential nutrition to infants and young patients with feeding difficulties due to various medical conditions.

• Adult: These kits typically feature a range of tube sizes and materials to accommodate different patient needs and medical conditions. They play a vital role in providing nutrition to adult patients with swallowing difficulties, neurological disorders, or those undergoing treatments that affect their ability to eat orally.

"Technological Advancements in Endoscopic Procedures to drive market advancement"

One of the key driving factors in the Percutaneous Endoscopic Gastrostomy Kit Market Growth is Technological Advancements in Endoscopic Procedures. Endoscopic procedures have witnessed substantial technological improvements over the years, making them safer, more efficient, and minimally invasive. These advancements include innovations in imaging technology, such as high-definition cameras and improved lighting systems, which enhance the visualization of the gastrointestinal tract during PEG tube placement. Additionally, the development of sophisticated endoscopic tools and accessories, such as specialized needles, guidewires, and dilation devices, has improved the precision and success rates of PEG tube insertions. These technological advancements not only contribute to better patient outcomes but also increase the adoption of PEG procedures by healthcare providers, thereby driving the demand for PEG kits in the market.

"Rising Incidence of Dysphagia and Malnutrition to Expand the Market"

Dysphagia, a condition characterized by difficulty swallowing, often results from various medical conditions such as stroke, neurological disorders, head and neck cancer, or aging-related changes in swallowing function. Malnutrition, which frequently accompanies dysphagia, poses significant health risks and compromises patients' quality of life. PEG tube insertion serves as a crucial intervention for individuals with dysphagia and malnutrition who are unable to consume adequate nutrition orally. As the global population ages and the prevalence of chronic diseases continues to rise, there is a growing demand for PEG procedures to manage dysphagia-related nutritional challenges. This increased demand directly translates into a higher requirement for PEG kits, thereby stimulating market growth.

"Regulatory Hurdles and Reimbursement Challenges Pose Potential Impediments to Market Growth"

The regulatory landscape governing medical devices, including PEG kits, is complex and subject to stringent requirements imposed by regulatory authorities such as the FDA (Food and Drug Administration) in the United States and the EMA (European Medicines Agency) in Europe. Manufacturers must navigate through rigorous premarket approval processes, clinical trials, and compliance with quality standards to obtain regulatory clearance or approval for their PEG kits, which can be time-consuming and resource-intensive. Moreover, reimbursement policies for PEG procedures vary across different healthcare systems and regions, leading to uncertainties and financial barriers for patients and healthcare providers. Inadequate reimbursement rates or coverage limitations may deter healthcare facilities from offering PEG services or influence clinicians' treatment decisions, thereby restraining the market growth of PEG kits.

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America to Dominate the Market Due to Favourable Regulatory Policies"

North America has emerged as the most dominant region in the Percutaneous Endoscopic Gastrostomy Kit Market Share. Firstly, the region exhibits a high prevalence of chronic diseases, including chronic obstructive pulmonary disease (COPD), neurodegenerative disorders, and head and neck cancers, all of which frequently necessitate enteral feeding via PEG tubes. This prevalence drives the demand for PEG procedures and associated kits. Secondly, North America boasts a well-established healthcare infrastructure with a substantial number of gastroenterologists and specialists proficient in performing PEG insertions. This infrastructure ensures accessibility to PEG services, further fuelling market growth. Thirdly, the continent benefits from favourable reimbursement policies, facilitating broader coverage and affordability of PEG tube placements compared to many other parts of the world. Lastly, there exists a high level of awareness among healthcare professionals and patients regarding the efficacy and advantages of PEG tubes in North America, contributing to increased adoption rates.

"Key Players Transforming the Distribution System Landscape through Innovation and Global Strategy"

Major industry players are pivotal in shaping the distribution system market, driving change through a dual strategy of continuous innovation and a well-thought-out global presence. By consistently introducing inventive solutions and staying at the forefront of technological progress, these key players redefine the industry's standards. Simultaneously, their expansive global reach enables effective market penetration, addressing diverse needs across borders. The seamless blend of groundbreaking innovation and a strategic international footprint positions these players as not only market leaders but also as architects of transformative shifts within the dynamic domain of distribution system.

• Fresenius Kabi (Germany)
• Cardinal Health (Switzerland)
• Nestle (Switzerland)
• Avanos Medical (U.S.)
• Danone (France)
• Applied Medical Technology (U.S.)
• Boston Scientific (U.S.)
• Cook Group (U.S.)

May 2023: Avanos Medical stands at the forefront of technological innovation in the realm of personalized nutrition initiatives. Through pioneering research and development efforts, Avanos leverages cutting-edge technologies to explore personalized nutrition solutions tailored to individuals' unique genetic makeup and gut microbiome composition. By harnessing the power of advanced analytics and molecular diagnostics, Avanos aims to revolutionize the field of nutrition by offering customized dietary interventions that optimize health outcomes and mitigate disease risks on a personalized level. This innovative approach not only represents a paradigm shift in how nutrition is conceptualized and implemented but also holds the promise of delivering more precise and effective nutritional interventions to improve overall health and well-being.

The Percutaneous Endoscopic Gastrostomy (PEG) Kit Market continues to witness steady growth driven by factors such as the rising prevalence of dysphagia and malnutrition, particularly in regions with aging populations, and technological advancements in endoscopic procedures. North America and Europe dominate the market due to their high incidence of chronic diseases, well-established healthcare infrastructure, favourable reimbursement policies, and heightened awareness of PEG kits. However, the market faces challenges stemming from regulatory hurdles and reimbursement complexities, which may hinder its full potential. Nonetheless, with ongoing research and development efforts, coupled with increasing demand for minimally invasive enteral feeding solutions, the PEG Kit Market is poised for sustained growth in the coming years.